Risk Manager
  • Solution
    • The Validated Approval Accelerator
      • Risk Management According to ISO 14971
      • Usability Engineering According to EN 62366
      • Essential Requirements According to MDR 2017/745 & IVDR 2017/746
      • Conformity Report for Medical Electrical Equipment According to EN 60601-1
      • Risk Management for IT Networks According to IEC 80001-1
      • Process Validation According to DIN EN ISO 13485
      • Clinical Evaluation According to MDR 2017/745 & MEDDEV 2.7.1
      • Software Lifecycle Process According to IEC 62304
    • References
      • What Our Customers Say – Success Stories
      • MST-Instrumente: Work and Time Savings
      • University Hospital rechts der Isar: Faultless Documentation and Achievement of the IEC 80001-1
      • Euroimmun: Cost Savings in Usability Engineering
      • biotrics bioimplants AG: Enrichment of the approval process by BAYOOSOFT Risk Manager
      • Selection from Our Customer List
      • Continuous Development since 1998 – Version History
  • Modules & Features
    • Modules
      • Risk Management
      • Usability Engineering
      • Essential Requirements
      • Medical Electrical Equipment
      • Machinery Directive
      • Requirements Engineering
      • Clinical Evaluation
      • Software Lifecycle Process
      • Medical IT Networks
      • REST API
      • Advanced Reporting
      • Pre-Validation Package
    • Features
      • Preliminary Hazard Analysis
      • Failure Mode and Effect Analysis
      • Structured Work According to Lifecycle Phase
      • Medical Device Classification
      • Post Market Surveillance
      • Self-Learning Knowledge Database
      • Fine-Grained Authorization Management
      • Visualizing with the Grey Box
  • Services
    • Services
      • Individual Services
      • Medical device classification
      • Software Validation – Your Service Options
      • License Model
      • System Requirements
      • Frequently Asked Questions
    • Contact
      • Upcomming Events
      • Test Now
      • Contact Request
  • Company
    • Company
      • About us
      • We think proactively
    • Our Partners
      • Get to know Our Partners
      • Become Partner now
  • Blog
  • Upcomming Events
  • Test Now
  • Customer Center
  • Search
  • Menu

Risk management in the development process of medical devices: Beginning and end?

Only when a medical device has been fully developed and is ready for market launch should manufacturers concern themselves with risk management. Right? Wrong! Risk management is an essential requirement for every medical device – before development, during the process, at market launch and beyond. Which steps in the development process are central and what you should consider in the risk analysis according to EN ISO 14971 – we describe it to you.

Good to know

The EU standard ISO 14971 is central to the risk management of medical devices. It describes the application of risk management to medical devices and thus a process to ensure that risks are known, controllable and acceptable compared to the benefits.

From the idea to placing on the market: The most important steps in the development of medical devices

First and foremost is the awareness of risk management. Manufacturers should prioritise and document this process from the beginning. ISO 14971 describes exactly how the risk management process should be set up. According to this, the process must include the following points:

  • Risk analysis

    Identify hazards, probabilities, severities and risks, decide on the acceptability of the risks.

  • Risk assessment

    Determine measures to minimise risks, analyse new risks on the basis of this (decide again on the justifiability of the risks).

  • Risk governance

    The central component of the technical documentation is the measures taken

  • Residual risk evaluation

    the re-evaluation provides information about new risks

  • Risk monitoring

    In the form of post-market surveillance

The beginning: product optimisation through risk analysis

The focus of risk management for medical devices is undoubtedly on the safety and health of patients and users. Every development therefore begins with a comprehensive analysis of possible risks, even before the first prototype is ready for demonstration. However, a well-documented risk analysis is not only indispensable for avoiding possible dangers for patients and users.

Identifying errors or unfeasible processes in production at an early stage optimises the product, saves time and thus reduces possible modification costs for manufacturers. It is important that the analysis covers the entire life cycle of the medical device and identifies all risks associated with use, maintenance and disposal. Only if all possible risks are prepared and documented in detail can a standard-compliant assessment of the risks be made.

Two procedures have become widely established for risk analysis: Preliminary Hazard Analysis (PHA) and Failure Mode and Effect Analysis (FMEA). While PHA follows the “top-down” principle as an approach – i.e. it becomes more and more specific from the general – FMEA uses a “button-up” method and works its way from the concrete to the general.

Mensch aus dem Gesundheitssektor sitzt vor grafischer Darstellung verschiedener Medical Symbole - Farbe Blau

More differences? 

Read more about it now in our blog.

Blog

The end: When is the risk management process complete?

One certainty remains in the development of medical devices: Risk management is not static and therefore never complete. ISO 14971 requires post-market surveillance – and this always brings to light new results and findings about the medical device. The documentation effort for manufacturers therefore remains even after the product has been placed on the market.

The efficient way to technical documentation

How can the risk management process be simplified for manufacturers of medical devices? The BAYOOSOFT Risk Manager supports you as the world’s leading software solution. All relevant information is recorded in a clearly structured environment, stored centrally in an audit-proof manner and linked dynamically in a fine-granular manner. In this way, you avoid redundant data storage. Reports are generated with the most up-to-date data at the touch of a button.

There are some special features to consider in the risk management of medical software. IEC 62304 applies here for the development and maintenance of medical device software. Read here how you as a manufacturer can implement the regulatory requirements, avoid unnecessary effort and achieve conformity.

get to know more
Sounds interesting? Share our post
  • Share on Facebook
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail

News

  • IEC 80001-1 Risikomanagement und KRITIS Risiko Critis RiskmanagementAre you sure that your CRITIS is secure?15. March 2023 - 14:04
  • BAYOOSOFT @ MEDICA 202231. October 2022 - 18:52
  • Medizintechnik Klinische BewertungClinical Evaluation: Seamless documentation13. October 2022 - 13:32
Contacts at BAYOOSOFT 

Svenja Winkler
CEO
[email protected]

 

 

Franziska Weiß
Head of Sales [email protected]

Darmstadt
Lise-Meitner-Straße 10
64293 Darmstadt

Munich
Aidenbachstraße 54
81379 München

Berlin 
Mariendorfer Damm 1-3
12099 Berlin

Phone: +49 (0) 6151 – 86 18 – 0
Fax: +49 (0) 6151 – 86 18 – 150

Contact: [email protected]
Support: [email protected]
Jobs: [email protected]
Press: [email protected]

  • Privacy Policy
  • Legal
IVDR – End of the transition period Zwei Mens General safety and performance requirements: What applies to medical devices...
Scroll to top